[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:lead-pharma-medicine-bv-09172969:header:guest:personal:":3,"case:lead-pharma-medicine-bv-09172969:overview:guest:personal::{}":81,"case:lead-pharma-medicine-bv-09172969:related":418},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":31,"termination_reason":32,"kvk_number":33,"legal_form":34,"sbi":14,"court":37,"judge":40,"judge_source":41,"curator":42,"location":48,"counts":58,"pages":63,"follower_count":62,"report_count":59,"last_report_on":75,"last_update_at":76,"freshness":77,"linked":80},"01M3SJFSJCWBFFNRZ7ERDWZQ0C","lead-pharma-medicine-bv-09172969","Lead Pharma Medicine B.V.",[],"terminated","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.01\u002F25\u002F159","2025-06-17","2026-09-29","lack_of_assets","09172969",{"value":35,"source":36},"BV","cir",{"name":38,"slug":39,"location":14},"Rechtbank Oost-Brabant","oost-brabant","mr. S.C.E.F. Moulen Janssen",{"type":36,"report_number":14,"published_on":14},{"name":43,"slug":44,"law_firm":45,"city":46,"verified":47},"mr. D.P. Schalken","dp-schalken","BG.Legal","'s-Hertogenbosch",false,{"street":49,"house_number":50,"addition":51,"postal_code":52,"city":53,"municipality":53,"province":54,"lat":55,"lng":56,"kind":57,"source":36},"Kloosterstraat","9","RK","5349AB","Oss","Noord-Brabant",51.760717,5.533719,"business",{"reports":59,"documents":60,"assets":61,"investigations":61,"news":62},4,13,6,0,{"overview":64,"reports":66,"financials":67,"investigations":68,"assets":69,"timeline":70,"documents":71,"news":72,"company":73,"compare":74},{"index":65,"ads":65},true,{"index":65,"ads":65},{"index":65,"ads":65},{"index":65,"ads":47},{"index":65,"ads":47},{"index":65,"ads":47},{"index":65,"ads":47},{"index":47,"ads":47},{"index":65,"ads":47},{"index":47,"ads":47},"2026-04-08","2026-10-04T17:34:33+00:00",{"last_checked_at":78,"last_reconciled_at":78,"stale":47,"status":79},"2026-10-11T04:06:37+00:00","current",{"continued_from":14,"continued_as":14},{"data":82},{"summary":83,"changes":150,"kpis":240,"topics":274,"topics_report_number":59,"topics_report_date":75,"processing":14,"timeline":341,"documents":398,"sources":414,"curator_update":14,"news":416,"auctions":417,"auction_count":62},{"kind":84,"category":84,"sentences":85,"facts":129,"published_at":149},"template",[86,91,94,98,103,111,117,123],{"key":87,"params":88,"facts":89},"declared",{"procedure":9,"date":30,"court":38,"number":29},[90],"procedure",{"key":8,"params":92,"facts":93},{"date":31},[8],{"key":95,"params":96,"facts":97},"curator",{"name":43},[95],{"key":20,"params":99,"facts":102},{"count":100,"number":14,"date":101},9,"2026-08-11",[20],{"key":104,"params":105,"facts":109},"value",{"field":106,"value":107,"state":108,"qualifier":14,"number":59,"date":75},"estate_assets",315857.06,"known",[110],"value_estate_assets",{"key":104,"params":112,"facts":115},{"field":113,"value":114,"state":108,"qualifier":14,"number":59,"date":75},"concurrent_claims",680175.99,[116],"value_concurrent_claims",{"key":104,"params":118,"facts":121},{"field":119,"value":120,"state":108,"qualifier":14,"number":59,"date":75},"creditor_count",21,[122],"value_creditor_count",{"key":104,"params":124,"facts":127},{"field":125,"value":126,"state":108,"qualifier":14,"number":59,"date":75},"preferential_claims",580086.57,[128],"value_preferential_claims",{"company":130,"procedure":132,"terminated":133,"curator":134,"reports":135,"value_estate_assets":136,"value_concurrent_claims":140,"value_creditor_count":143,"value_preferential_claims":146},{"category":131},"official",{"category":131},{"category":131},{"category":131},{"category":131},{"category":137,"value_id":138,"reference_id":139},"automated",45712,372179,{"category":137,"value_id":141,"reference_id":142},13651,318122,{"category":137,"value_id":144,"reference_id":145},13650,318121,{"category":137,"value_id":147,"reference_id":148},13652,318123,"2026-10-09T07:57:19+00:00",{"from":151,"to":155,"count":157,"groups":158},{"id":152,"number":153,"published_on":154},"01M3SJFZZX1K9WBY6WZ9W86CVW",3,"2026-01-14",{"id":156,"number":59,"published_on":75},"01M3SJG4ZHENMD35XVB72FSVJQ",7,{"new":159,"changed":160,"completed":226,"ongoing":238,"no_longer_mentioned":239},[],[161,182,194,206,214,221],{"kind":162,"field":113,"change":163,"from":164,"to":166,"delta":167,"delta_ratio":168,"source":169},"amount","changed",{"value":165,"state":108,"qualifier":14},669975.99,{"value":114,"state":108,"qualifier":14},10200,0.0152,{"id":142,"category":137,"method":170,"source_type":171,"document":172,"page":177,"section":178,"excerpt":179,"certainty":180,"curator_verified_at":14,"processed_at":181},"deterministic","cir_report",{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"01M3SJG6EV72GZJ4NWXZ6V4RQB","Verslag: 08-04-2026",17,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG6EV72GZJ4NWXZ6V4RQB.pdf",15,"8.6 Bedrag concurrente crediteuren","€ 662.535,77 Toelichting Van dit bedrag bestaat EUR 625.393,20 uit voorafgaand aan faillietverklaring verschuldigde huurpenningen. De huurbetaling w as als gevolg van een eind 2024 gemaakte afspraak met de verhuurder uitgesteld.",0.95,"2026-10-02T18:43:03+00:00",{"kind":183,"field":119,"change":163,"from":184,"to":186,"delta":187,"delta_ratio":188,"source":189},"count",{"value":185,"state":108,"qualifier":14},20,{"value":120,"state":108,"qualifier":14},1,0.05,{"id":145,"category":137,"method":170,"source_type":171,"document":190,"page":191,"section":192,"excerpt":193,"certainty":180,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},14,"8.5 Aantal concurrente crediteuren","7",{"kind":195,"topic":196,"change":163,"from":197,"to":198,"source":199},"topic","bookkeeping_duty","investigating","mentioned",{"id":200,"category":137,"method":170,"source_type":171,"document":201,"page":202,"section":203,"excerpt":204,"certainty":205,"curator_verified_at":14,"processed_at":181},318135,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},11,"7.1 Boekhoudplicht","Voldaan.",0.5,{"kind":195,"topic":207,"change":163,"from":197,"to":198,"source":208},"director_liability",{"id":209,"category":137,"method":170,"source_type":171,"document":210,"page":211,"section":212,"excerpt":213,"certainty":205,"curator_verified_at":14,"processed_at":181},318136,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},12,"7.5 Onbehoorlijk bestuur","Toelichting Er is geen sprake van onbehoorlijk bestuur. De gemaakte intercompany-afspraken over de toebedeling van kosten en activa binnen het concern w erd achterhaald door het uitgesproken faillissement van Lead Pharma Holding B.V.",{"kind":195,"topic":215,"change":163,"from":197,"to":198,"source":216},"paulianas",{"id":217,"category":137,"method":170,"source_type":171,"document":218,"page":211,"section":219,"excerpt":220,"certainty":205,"curator_verified_at":14,"processed_at":181},318137,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"7.6 Paulianeus handelen","Nee Toelichting Er is geen sprake van paulianeus handelen.",{"kind":195,"topic":222,"change":163,"from":197,"to":198,"source":223},"legality_review",{"id":224,"category":137,"method":170,"source_type":171,"document":225,"page":202,"section":203,"excerpt":204,"certainty":205,"curator_verified_at":14,"processed_at":181},318138,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},[227],{"kind":195,"topic":228,"change":229,"from":198,"to":229,"source":230},"causes_investigation","completed",{"id":231,"category":137,"method":170,"source_type":171,"document":232,"page":233,"section":234,"excerpt":235,"certainty":236,"curator_verified_at":14,"processed_at":237},134802,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},5,"1.5 Oorzaak faillissement","Tot heden is de curator het volgende gebleken uit gesprekken met het bestuur en betrokkenen, maar dit vormt geen conclusie. Lead Pharma Medicine B.V. exploiteert een farmaceutisch onderzoeks- en ontw ikkelbedrijf. Daartoe verricht zij onderzoek naar nieuw e medicijnen ter genezing van kanker en auto-immuunziekten. Medicijnonderzoek is een langdurig en kostbaar traject. Van een idee naar verkoop du",0.7,"2026-09-30T16:31:29+00:00",[],[],{"values":241,"reports":270},[242,253,257,263,267],{"field":106,"kind":162,"value":107,"state":108,"qualifier":14,"as_of":75,"category":137,"report_number":59,"report_date":75,"source":243,"previous":250,"delta":252,"curator":14,"processing":47,"correction_pending":47,"conflict":14},{"id":139,"category":137,"method":170,"source_type":171,"document":244,"page":61,"section":248,"excerpt":249,"certainty":180,"curator_verified_at":14,"processed_at":76},{"id":245,"title":246,"report_number":59,"report_date":75,"published_on":75,"page_count":100,"url":247,"available":65},"01M3SJG4YYAPBHX0ZT5CMQ61T4","Financieel verslag 08-04-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG4YYAPBHX0ZT5CMQ61T4.pdf","financial_statement_a","Totaal baten                                         € 315.857,06                      € 54.548,53",{"value":251,"state":108,"report_number":153,"report_date":154},315647.65,209.41,{"field":113,"kind":162,"value":114,"state":108,"qualifier":14,"as_of":75,"category":137,"report_number":59,"report_date":75,"source":254,"previous":256,"delta":167,"curator":14,"processing":47,"correction_pending":47,"conflict":14},{"id":142,"category":137,"method":170,"source_type":171,"document":255,"page":177,"section":178,"excerpt":179,"certainty":180,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},{"value":165,"state":108,"report_number":153,"report_date":154},{"field":125,"kind":162,"value":126,"state":108,"qualifier":14,"as_of":75,"category":137,"report_number":59,"report_date":75,"source":258,"previous":262,"delta":62,"curator":14,"processing":47,"correction_pending":47,"conflict":14},{"id":148,"category":137,"method":170,"source_type":171,"document":259,"page":191,"section":260,"excerpt":261,"certainty":180,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"8.2 Pref. vord. van de fiscus","€ 193.905,00 Toelichting Dit bedrag zal nog verder oplopen.",{"value":126,"state":108,"report_number":153,"report_date":154},{"field":119,"kind":183,"value":120,"state":108,"qualifier":14,"as_of":75,"category":137,"report_number":59,"report_date":75,"source":264,"previous":266,"delta":187,"curator":14,"processing":47,"correction_pending":47,"conflict":14},{"id":145,"category":137,"method":170,"source_type":171,"document":265,"page":191,"section":192,"excerpt":193,"certainty":180,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},{"value":185,"state":108,"report_number":153,"report_date":154},{"field":268,"kind":183,"value":14,"state":269,"qualifier":14,"as_of":14,"category":14,"report_number":14,"report_date":14,"source":14,"previous":14,"delta":14,"curator":14,"processing":47,"correction_pending":47,"conflict":14},"employee_count","not_mentioned",{"count":59,"next":271},{"interval_days":272,"next_on":273},89,"2026-07-06",[275,282,285,292,299,307,314,317,324,327,330,338],{"topic":276,"investigation":47,"state":198,"category":137,"source":277},"lease_contracts",{"id":278,"category":137,"method":170,"source_type":171,"document":279,"page":59,"section":280,"excerpt":281,"certainty":205,"curator_verified_at":14,"processed_at":181},318127,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"1.4 Huur","Afgelopen verslagperiode is een schikking bereikt met de verhuurder over de oplevering, de vaststelling van de diverse vorderingen en de afrekening van 4 de zekerhedenpositie.",{"topic":228,"investigation":65,"state":229,"category":137,"source":283},{"id":231,"category":137,"method":170,"source_type":171,"document":284,"page":233,"section":234,"excerpt":235,"certainty":236,"curator_verified_at":14,"processed_at":237},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},{"topic":286,"investigation":47,"state":198,"category":137,"source":287},"employees",{"id":288,"category":137,"method":170,"source_type":171,"document":289,"page":61,"section":290,"excerpt":291,"certainty":205,"curator_verified_at":14,"processed_at":237},134803,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"2.3 Ontslagaanzegging","Datum Aantal Toelichting 20-6-2025 18 totaal 18",{"topic":293,"investigation":47,"state":198,"category":137,"source":294},"asset_sales",{"id":295,"category":137,"method":170,"source_type":171,"document":296,"page":61,"section":297,"excerpt":298,"certainty":205,"curator_verified_at":14,"processed_at":237},134804,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"3.1 Onroerende zaken","Beschrijving Verkoopopbr. Hypotheek Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 Toelichting onroerende zaken",{"topic":300,"investigation":47,"state":198,"category":137,"source":301},"receivables_collection",{"id":302,"category":137,"method":170,"source_type":171,"document":303,"page":304,"section":305,"excerpt":306,"certainty":205,"curator_verified_at":14,"processed_at":237},134809,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},8,"4.1 Debiteuren","Beschrijving Omvang Opbrengst Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 € 0,00 Toelichting debiteuren Failliet is afhankelijk van investeerders en overheidsinstellingen. Er w erden geen facturen gestuurd.",{"topic":308,"investigation":47,"state":198,"category":137,"source":309},"security_rights",{"id":310,"category":137,"method":170,"source_type":171,"document":311,"page":100,"section":312,"excerpt":313,"certainty":205,"curator_verified_at":14,"processed_at":181},318129,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"5.3 Beschrijving zekerheden","Er is een schikking bereikt met de pandhouder c.q. verhuurder, die inmiddels ook is uitgevoerd. Dit is dus afgerond.",{"topic":196,"investigation":65,"state":198,"category":137,"source":315},{"id":200,"category":137,"method":170,"source_type":171,"document":316,"page":202,"section":203,"excerpt":204,"certainty":205,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},{"topic":318,"investigation":65,"state":229,"category":137,"source":319},"annual_accounts_filing",{"id":320,"category":137,"method":170,"source_type":171,"document":321,"page":211,"section":322,"excerpt":323,"certainty":236,"curator_verified_at":14,"processed_at":237},134817,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},"7.2 Depot jaarrekeningen","De jaarrekening 2023 is gedeponeerd op 4 juli 2024.",{"topic":207,"investigation":65,"state":198,"category":137,"source":325},{"id":209,"category":137,"method":170,"source_type":171,"document":326,"page":211,"section":212,"excerpt":213,"certainty":205,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},{"topic":215,"investigation":65,"state":198,"category":137,"source":328},{"id":217,"category":137,"method":170,"source_type":171,"document":329,"page":211,"section":219,"excerpt":220,"certainty":205,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},{"topic":331,"investigation":65,"state":198,"category":137,"source":332},"proceedings",{"id":333,"category":137,"method":170,"source_type":171,"document":334,"page":335,"section":336,"excerpt":337,"certainty":205,"curator_verified_at":14,"processed_at":237},134820,{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},16,"9.1 Naam wederpartijen","Er is niet gebleken van procedures.",{"topic":222,"investigation":65,"state":198,"category":137,"source":339},{"id":224,"category":137,"method":170,"source_type":171,"document":340,"page":202,"section":203,"excerpt":204,"certainty":205,"curator_verified_at":14,"processed_at":181},{"id":173,"title":174,"report_number":59,"report_date":75,"published_on":75,"page_count":175,"url":176,"available":65},[342,352,357,365,372],{"id":343,"type":344,"group":90,"category":131,"occurred_at":345,"detected_at":346,"date_basis":347,"payload":348,"from_case":14,"source":14},"01M3SJFSMMPXYSF57HT2H28SJG","publication_added","2026-09-30T00:00:00+00:00","2026-09-30T16:31:13+00:00","source",{"publication_id":349,"type":350,"description":351},"01M3SJFSM4FTZCD4RW2MVXCTP3","termination","Opheffing faillissement wegens gebrek aan baten op 29 september 2026",{"id":353,"type":354,"group":90,"category":131,"occurred_at":355,"detected_at":346,"date_basis":347,"payload":356,"from_case":14,"source":14},"01M3SJFSMQX323HXVS9X469T2G","case_terminated","2026-09-29T00:00:00+00:00",{"status":8,"reason":32},{"id":358,"type":359,"group":20,"category":131,"occurred_at":360,"detected_at":361,"date_basis":347,"payload":362,"from_case":14,"source":14},"01M3SJG819ESJGTAAKMA93J97Z","report_published","2026-08-11T12:00:00+00:00","2026-09-30T16:31:28+00:00",{"report_id":363,"report_number":14,"report_date":101,"title":364,"is_final":47},"01M3SJG6FEAWMH3848H04YH4D5","Financieel verslag  04-08-2026",{"id":366,"type":344,"group":90,"category":131,"occurred_at":367,"detected_at":346,"date_basis":347,"payload":368,"from_case":14,"source":14},"01M3SJFSMHNTZBKNQ3HZNMJF2C","2026-05-13T00:00:00+00:00",{"publication_id":369,"type":370,"description":371},"01M3SJFSM3Z6MEWKZGNM4HV5W9","other","Vereenvoudigde afwikkeling van het faillissement",{"id":373,"type":374,"group":375,"category":137,"occurred_at":376,"detected_at":76,"date_basis":347,"payload":377,"from_case":14,"source":14},"01M43ZPMHXVZN6717B8YS6EP76","financial_changed","financial","2026-04-08T12:00:00+00:00",{"from_report":378,"to_report":379,"from_number":153,"to_number":59,"from_date":154,"to_date":75,"fields":380},"01M3SJG1NNPSYYN830PZWANSXG","01M3SJG386F9XHFPVQ99ZCXF6P",[381,384,391],{"field":106,"from":382,"to":383,"delta":252},{"value":251,"state":108,"qualifier":14},{"value":107,"state":108,"qualifier":14},{"field":385,"from":386,"to":388,"delta":390},"estate_claims",{"value":387,"state":108,"qualifier":14},820,{"value":389,"state":108,"qualifier":14},248327.33,247507.33,{"field":392,"from":393,"to":395,"delta":397},"estate_account_balance",{"value":394,"state":108,"qualifier":14},285544.57,{"value":396,"state":108,"qualifier":14},164753.98,-120790.59,[399,404,409,413],{"kind":400,"id":349,"title":351,"report_number":14,"date":401,"pages":187,"category":131,"url":14,"publication_type":350,"publication_number":402,"stored_at":346,"download_url":403},"publication","2026-09-30","01.obr.25.159.F.1316.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM4FTZCD4RW2MVXCTP3\u002Fdownload",{"kind":405,"id":406,"title":364,"report_number":14,"report_date":101,"date":101,"pages":407,"category":131,"url":408},"report","01M3SJG816Q8VPXB9KRPS86W8P",10,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG816Q8VPXB9KRPS86W8P.pdf",{"kind":400,"id":369,"title":371,"report_number":14,"date":410,"pages":187,"category":131,"url":14,"publication_type":370,"publication_number":411,"stored_at":346,"download_url":412},"2026-05-13","01.obr.25.159.F.1308.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM3Z6MEWKZGNM4HV5W9\u002Fdownload",{"kind":405,"id":173,"title":174,"report_number":59,"report_date":75,"date":75,"pages":175,"category":131,"url":176},{"official":60,"curator":62,"automated":415,"external":62},74,[],[],{"sector":14,"cases":419},[]]